BioSpace News Archive

Johnson & Johnson will host a conference call for investors at 8:30 a.m. on Tuesday, October 15th to review third-quarter results.

Invacare Corporation (NYSE: IVC) today announced the appointment of Julie Beck to its Board of Directors, effective September 18, 2019.

On the first World Patient Safety Day, the Patient Safety Movement Foundation (PSMF) announces that it has awarded Dignity Health, MedStar Health and the UPMC with its five-star award for making commitments in alignment with PSMF’s 18 evidence-based Actionable Patient Safety Solutions (APSS).

On September 5, 2019, the BC government announced phase two of its Biosimilars Initiative, informing patients prescribed the originator biologic drug, Remicade® (infliximab), to treat inflammatory bowel disease (Crohn’s disease and ulcerative colitis) that this medication will no longer be covered by the province, and that they must switch to a biosimilar infliximab, either Inflectra® or Renflexis®